Michael D. Arrington

Michael Arrington practices at CHRISTUS Mother Frances Hospital - Tyler in Tyler, Texas, part of CHRISTUS Health.

Michael Arrington's NPI, 1831519453, was assigned on April 22, 2014. Michael Arrington graduated from Texas a & M University System, Hsc, College of Medicine in 2014. Michael Arrington holds Texas license R3263.

Michael Arrington's primary practice is CHRISTUS Mother Frances Hospital - Tyler, at 800 East Dawson, Tyler, TX 75701 in Smith County. The practice phone is (903) 593-8441.

Michael Arrington's primary practice is CHRISTUS Mother Frances Hospital - Tyler in Tyler, Texas, part of CHRISTUS Health. Michael Arrington is also affiliated with CHRISTUS Mother Frances Hospital - Sulphur Springs. The medical group on file is CHRISTUS Mother Frances Hospital - Tyler. Dmand AI also links Michael Arrington to 2 more medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Michael Arrington practices, 2 sites in all. Vendor and product names are available with a free account.

Emergency medicine is Michael Arrington's primary specialty in the NPI Registry, under taxonomy code 207P00000X. Michael Arrington is licensed in Texas.

CMS data shows 992 Medicare services from Michael Arrington across 4 procedure codes in 2024, for 693 Medicare patients. Medicare paid $91,989 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 693 Medicare patients who saw Michael Arrington in 2024. The largest group is 75 to 84, with 259 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 16% are also on Medicaid. Their average risk score is 1.89, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Michael Arrington's median patient age at 58, with 54% women.

In 2024, Michael Arrington wrote 713 Medicare Part D claims for 429 patients. 95% of them were for generic drugs. CMS names the drug for 524 of them, across 15 drugs with 11 or more claims each, at $3,965 in total drug cost. In 2023, CMS named 485 claims across 14 drugs.

Michael Arrington accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 2 papers to Michael Arrington, published from 2023 to 2025. Michael Arrington has published most often in Biomed Opt Express. Michael Arrington's most frequent co-authors are Feras Akbik, MD, PhD, Beatrice Gee, MD and Ofer Sadan, MD, PhD.

Michael Arrington graduated from Texas a & M University System, Hsc, College of Medicine in 2014.